U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. lifted its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 26.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 87,501 shares of the company's stock after acquiring an additional 18,484 shares during the period. JPMorgan Chase & Co. owned 0.58% of U.S. Physical Therapy worth $7,762,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp lifted its stake in U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after purchasing an additional 99,244 shares during the last quarter. Geode Capital Management LLC boosted its stake in U.S. Physical Therapy by 1.3% in the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company's stock valued at $29,040,000 after acquiring an additional 4,477 shares in the last quarter. HighTower Advisors LLC increased its position in shares of U.S. Physical Therapy by 13.6% during the third quarter. HighTower Advisors LLC now owns 4,714 shares of the company's stock worth $399,000 after purchasing an additional 566 shares in the last quarter. PNC Financial Services Group Inc. lifted its holdings in shares of U.S. Physical Therapy by 37.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company's stock valued at $409,000 after purchasing an additional 1,254 shares during the last quarter. Finally, Copeland Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after purchasing an additional 72,715 shares during the period.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several analysts recently commented on USPH shares. JPMorgan Chase & Co. reduced their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. StockNews.com cut U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Thursday, April 17th. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. JMP Securities restated a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday. Finally, Barrington Research dropped their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Price Performance

U.S. Physical Therapy stock traded up $0.70 during mid-day trading on Tuesday, reaching $67.01. The company had a trading volume of 2,076 shares, compared to its average volume of 106,388. The company has a market capitalization of $1.02 billion, a P/E ratio of 71.49, a P/E/G ratio of 3.54 and a beta of 1.38. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The stock's 50-day simple moving average is $76.06 and its 200-day simple moving average is $84.71. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $108.14.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to analysts' expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 14th were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.69%. The ex-dividend date of this dividend was Friday, March 14th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's dividend payout ratio is 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.